Llwytho...
LAMA/LABA vs ICS/LABA in the treatment of COPD in Japan based on the disease phenotypes
In the combined use of bronchodilators of different classes, ie, long-acting β(2)-agonists (LABAs) and long-acting muscarinic antagonists (LAMAs), bronchodilation is obtained both directly, through LABA-mediated stimulation of β(2)-adrenergic receptors, and indirectly, through LAMA-mediated inhibiti...
Wedi'i Gadw mewn:
| Cyhoeddwyd yn: | Int J Chron Obstruct Pulmon Dis |
|---|---|
| Prif Awdur: | |
| Fformat: | Artigo |
| Iaith: | Inglês |
| Cyhoeddwyd: |
Dove Medical Press
2015
|
| Pynciau: | |
| Mynediad Ar-lein: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4468951/ https://ncbi.nlm.nih.gov/pubmed/26089659 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/COPD.S72858 |
| Tagiau: |
Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!
|